Clinical Trial Update: Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating 18F-DCFPyL PET/CT imaging for suspected recurrence of prostate cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Drugs mentioned

• 18F-DCFPyL PET/CT imaging (18F-DCFPyL)

Snippet

Sponsor: Progenics Pharmaceuticals, Inc. | Conditions: Prostate Cancer, Prostate Adenocarcinoma | Phase 3 | Status: COMPLETED | Results posted: 2021-06-14